Intravesical BCG induces CD4(+) T-Cell Expansion in an Immune Competent Model of Bladder Cancer

Intravesical BCG immunotherapy is the standard of care in treating non-muscle invasive bladder cancer, yet its mechanism of action remains elusive. Both innate and adaptive immune responses have been implicated in BCG activity. Although prior research has indirectly demonstrated the importance of T...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Immunol Res
Autors principals: Kates, Max, Nirschl, Thomas, Sopko, Nikolai A., Matsui, Hotaka, Kochel, Christina M., Reis, Leonardo O., Netto, George J., Hoque, Mohammad, Hahn, Noah M., McConkey, David J., Baras, Alex S., Drake, Charles G., Bivalacqua, Trinity J.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5536898/
https://ncbi.nlm.nih.gov/pubmed/28588015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-16-0267
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars